nasopharyngeal carcinoma
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: A. Stage II-IVB nasopharyngeal carcinoma was diagnosed in our hospital; B. Age between 18 and 70 years; C. Nasopharyngeal carcinoma is histologically or cytologically confirmed; D. Behavior status score ECOG: 0-1 points; E. Normal bone marrow, liver and kidney function.
Exclusion criteria
Exclusion criteria: A. New program has previously received anti-tumor treatment for nasopharyngeal carcinoma (chemotherapy, radiation, targeted therapy, or immunotherapy); B. has suffered from other malignancies for nearly three years; C. Any unstable systemic disease, including active infection, uncontrolled hypertension, unstable anginal, myocardial infarction (), (6 months), cardiac function failure (cardiac function), severe cardiac arrhythmia, severe liver and kidney disease; D. the opposite of the medicine; E. hepatitis b, hepatitis c or HIV positive; F. pregnancy or lactating woman; G. The g. researchers determined that the patient was not involved.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| complete response;partial response;partial response;progressive disease;standard uptake value;influx constant,Ki; | — |
Countries
China
Contacts
The Fifth Affiliated Hospital of Sun Yat-Sen University